Pharmaceuticals maker Pfizer Inc. ( PFE ) on Monday saw its earnings estimates lifted by analysts at Goldman Sachs.
The firm said it boosted its estimates for PFE through 2015, noting that new products should help drive earnings growth. The firm maintained its "Buy" rating and $22 price target on PFE, suggesting a 21% upside to the stock's Friday closing price of $18.21.
Pfizer shares rose 54 cents, or +3%, in premarket trading Monday.
The Bottom Line
Shares of Pfizer ( PFE ) have a 4.39% dividend yield, based on Friday's closing stock price of $18.21. The stock has technical support in the $16-$17 price area. If the shares can firm up, we see overhead resistance around the $20 price level.
Pfizer Inc. ( PFE ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Created by Dividend.com
Latest Markets Videos
- The $12 Trillion "Once-in-a-Lifetime" Market Opportunity Investors Won't Want to Miss
- J.P. Morgan Says These 3 Stocks Could Surge Over 100% From Current Levels
- Forget Tesla's Battery Day, These EV Stories Are More Important
- ChargePoint, Switchback Energy Acquisition Enter Business Combination Agreement